Search publications
18 results found
-
European Commission to assess the acquisition of Oticon Medical by Cochlear
The European Commission will assess the acquisition of Oticon Medical by Cochlear. Both Oticon Medical and Cochlear are manufacturers of specialist cochlear implants and bone-anchored hearing aids. Several EU countries, including the Netherlands, had … -
ACM: anti-competitive risks for some medical devices
The Netherlands Authority for Consumers and Markets (ACM) sees anticompetitive risks in some markets for medical devices. With regard to high-technological medical devices in particular, there are relatively few providers, and new providers face high … -
ACM guidelines regarding the competition rules for the health care IT market have been well received
The guidelines called ‘Well-functioning markets for health care IT’ clarifies the application of the competition rules for improving the functioning of the market for health care IT systems. In the summer of 2022, the Netherlands Authority for Consumers … -
ACM’s response to joint COVID arrangements between ZN, NVZ and NFU for 2022
Going forward, hospitals and health insurers are only allowed to make joint arrangements regarding the reimbursement of COVID-19-related costs if the nationwide continuity of health care is seriously jeopardized. That is one of the conclusions of the … -
ACM guidelines to clarify competition rules for health care IT markets
No impediments to the exchange of data, no abuse of vendor lock-in, but, at the same time, giving room to collaborative procurement among health care providers, and the use of standards. These are some of the recommendations in the draft version of the … -
Drug manufacturer Pfizer to discontinue its steering pricing structure for Enbrel following discussions with ACM
Drug manufacturer Pfizer will no longer persuade hospitals in the Netherlands into purchasing anti-rheumatic drug Enbrel through its discount schemes. Pfizer has informed the Netherlands Authority for Consumers and Markets (ACM) of its plans. This will … -
ACM’s response to planned distribution of COVID-19-related costs among health insurers in 2021
Health insurers in 2021 may still distribute the exceptional additional costs related to the COVID-19 pandemic among each other. This has been the answer of the Netherlands Authority for Consumers and Markets (ACM) in response to questions posed by ZN … -
ACM’s response to arrangements between ZN, NVZ, and NFU regarding COVID-19-related costs for 2021
Health insurers and hospitals can make arrangements regarding financial assistance in 2021 in order to prevent far-reaching consequences of the coronavirus (COVID-19) pandemic. The Netherlands Authority for Consumers and Markets (ACM) has approved this … -
Room for collaborations as part of ‘the Right Care in the Right Place’
Health care providers and health insurers have to collaborate, as part of the initiative called ‘the Right Care in the Right Place’ (in Dutch: De Juiste Zorg op de Juiste Plek). Many forms of collaborations are allowed. However, collaborations can also go … -
ACM Policy Rule on arrangements as part of the movement called ‘The right care in the right place’ (JZOJP)
Health care providers and health insurers have to collaborate, as part of the initiative called ‘the Right Care in the Right Place’ (in Dutch: De Juiste Zorg op de Juiste Plek). Many forms of collaborations are allowed. However, collaborations can also go …